You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Details for Patent: 11,357,753

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 11,357,753 protect, and when does it expire?

Patent 11,357,753 protects BARHEMSYS and is included in one NDA.

This patent has sixteen patent family members in twelve countries.

Summary for Patent: 11,357,753

Title:	Rescue treatment of post operative nausea and vomiting
Abstract:	Amisulpride is useful in the treatment of postoperative nausea and/or vomiting in a patient, wherein the patient has already been administered a prophylaxis drug for postoperative nausea and/or vomiting, and wherein the dose of amisulpride is 7.5 to 15 mg.
Inventor(s):	Gilbert; Julian Clive (Cambridge, GB), Gristwood; Robert William (Cambridge, GB), Fox; Gabriel (Cambridge, GB)
Assignee:	Acacia Pharma Ltd (Duxford, GB)
Application Number:	16/485,008
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 11,357,753

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Acacia	BARHEMSYS	amisulpride	SOLUTION;INTRAVENOUS	209510-001	Feb 26, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING	⤷ Sign Up
Acacia	BARHEMSYS	amisulpride	SOLUTION;INTRAVENOUS	209510-002	Sep 1, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				TREATMENT OF POST-OPERATIVE NAUSEA AND VOMITING	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 11,357,753

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	1702250	Feb 10, 2017

PCT Information
PCT Filed	February 09, 2018	PCT Application Number:	PCT/GB2018/050374
PCT Publication Date:	August 16, 2018	PCT Publication Number:	WO2018/146490

International Family Members for US Patent 11,357,753

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2018218310	⤷ Sign Up
Brazil	112019016565	⤷ Sign Up
Canada	3052535	⤷ Sign Up
China	110603036	⤷ Sign Up
Eurasian Patent Organization	201991667	⤷ Sign Up
European Patent Office	3579831	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.